Tesla's disappointing quarterly results put pressure on the shares of the electric car manufacturer.
In the coming days and weeks, Wall Street will be monitoring company results closely. The «Magnificent Seven» are likely to attract particular attention as their shares have risen sharply in 2023.
Bonus Certificate Nestlé, Novartis und Roche
«ZKB Favourite Stocks 2024»: Building Exposure with Reverse Convertibles
The research at Zürcher Kantonalbank has identified ten equity top picks for the new year. The tracker certificate on the «ZKB Favourite Stocks 2024» allows investors to participate in this selection.
A few trading days remain until the end of the year. After the loss-making previous year, the Swiss Market Index is set to post a positive performance.
The shares of Basel-based pharmaceutical group Roche remain a source of concern for investors this year. We think the outlook for 2024 is slightly better. However, the shares remain exposed to risk.
In the past, European luxury goods companies were among the stock market favourites. This year has been different.
| ZKB Barrier Reverse Convertible on worst of Davide Campari - Milano N.V./Pernod Ricard SA/Remy Coint... 147481074 / CH1474810749 |
| ZKB Reverse Convertible on worst of PUMA SE/adidas AG 142529647 / CH1425296477 |
| ZKB Autocallable Barrier Reverse Convertible auf Palantir Technologies Inc 147480637 / CH1474806374 |
| ZKB Barrier Reverse Convertible on worst of Alibaba Group Holding Ltd/Baidu Inc 149280963 / CH1492809632 |
| ZKB Barrier Reverse Convertible on worst of Infineon Technologies AG/BASF SE/adidas AG/Mercedes-Benz... 140252563 / CH1402525633 |